NOX vs RHT

ASX Healthcare sector comparison — updated 3 Sep 2026 — Healthcare sector

NOX

NOXOPHARM FPO [NOX]

53MEDIUM

RHT

RESONANCE FPO [RHT]

60MEDIUM-HIGH

Score Breakdown

NOX RHT
Technical
57
52
Catalyst
55
52
Sentiment
50
50
Fundamental
37
91
Momentum
54
76
Risk Gate
46
50

Key Metrics

NOX Metric RHT
$24.9MMarket Cap$28.6M
77KAvg Volume (20d)388K
N/AShort InterestN/A
$0.11052-Week High$0.068
$0.05152-Week Low$0.033
-1.2%Daily Change-3.3%
$0.080Reference Price$0.058
N/AROE+14.8%
N/AProfit Margin+9.6%

Active Signals

NOX Signals

RSI drifting toward oversold territory — worth watching
MACD momentum is losing steam
Drifting lower — down 4.8% over the last 5 days
Volume-price trend says buyers are quietly accumulating — price hasn't caught up yet
Trading above the 200-day average — the long-term trend is on your side
Critical cash runway (0.4 quarters)
4C filed 2026-07-21
Piotroski F-Score weak (2/9, low-confidence approx)

RHT Signals

MACD momentum is losing steam
Smart money may be accumulating — volume is flowing in even though price hasn't moved yet
Trading above the 200-day average — the long-term trend is on your side
Cash positive / operating cashflow positive
Low P/S ratio (1.8x)
Strong revenue growth (+31%)
Piotroski F-Score strong (7/9, low-confidence approx)
Small-cap ($20-100M)

Ask Scout AI to compare NOX and RHT in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

LDX vs SPL →BLS vs SPL →ATX vs SPL →BLS vs LDX →ATX vs LDX →
NOX Full Analysis → RHT Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).